ACUTE ISCHEMIC STROKE FROM LARGE VESSEL OCCLUSION
Clinical trials for ACUTE ISCHEMIC STROKE FROM LARGE VESSEL OCCLUSION explained in plain language.
Never miss a new study
Get alerted when new ACUTE ISCHEMIC STROKE FROM LARGE VESSEL OCCLUSION trials appear
Sign up with your email to follow new studies for ACUTE ISCHEMIC STROKE FROM LARGE VESSEL OCCLUSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common diabetes pill protect the brain after a stroke?
Disease control Not yet recruitingThis study tests whether canagliflozin, a diabetes drug, can reduce dangerous brain swelling and bleeding in people who have had a severe stroke and are receiving clot-removal therapy. About 150 adults will be randomly assigned to take the drug for 14 days or receive standard car…
Matched conditions: ACUTE ISCHEMIC STROKE FROM LARGE VESSEL OCCLUSION
Phase: PHASE4 • Sponsor: Taichung Veterans General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Could a simple blood protein boost stroke recovery?
Disease control Not yet recruitingThis Phase 2 trial tests whether giving human albumin directly into the artery supplying the brain, right after a clot is removed, can improve recovery in people with severe stroke. About 306 participants will be randomly assigned to receive either standard clot removal alone or …
Matched conditions: ACUTE ISCHEMIC STROKE FROM LARGE VESSEL OCCLUSION
Phase: PHASE2 • Sponsor: Tianjin Huanhu Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
Could a simple protein infusion boost stroke recovery?
Disease control Not yet recruitingThis study tests whether giving a protein called albumin directly into the artery during a stroke procedure can reduce brain damage. Sixty adults with a severe stroke will receive either standard treatment alone or standard treatment plus albumin. The goal is to see if albumin he…
Matched conditions: ACUTE ISCHEMIC STROKE FROM LARGE VESSEL OCCLUSION
Phase: PHASE2 • Sponsor: Tianjin Huanhu Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC